Cortagen
Cortagen is a research reference peptide composed of 4 amino acids (tetrapeptide). Structural class: Synthetic short peptide (Khavinson bioregulator class). Reported molecular weight: 430.41 Da. Listed for research and educational reference only.
| Also known as | Brain Cortex Tetrapeptide (AEDP), Neuroprotective Bioregulator |
|---|---|
| Evidence level | Limited Research |
| Regulatory status | Research-only |
| Molecular weight | 430.41 Da |
| Chain length | 4 amino acids (tetrapeptide) |
| Class | Synthetic short peptide (Khavinson bioregulator class) |
| Sequence | Ala-Glu-Asp-Pro (H-A-E-D-P-OH) |
| Notes | Linear unmodified L-tetrapeptide, Molecular formula C17H26N4O9, Synthetic analog of active fragments from bovine brain cortex extract (Cortexin), Distinct from Cardiogen (AEDR, pos |
| Updated | 2026-10-12 |
Cortagen is a lab-made brain-cortex tetrapeptide — a small molecule built from four amino-acid building blocks — in the Khavinson bioregulator family of short regulatory peptides. It appears in neural and anti-aging research literature and is supplied lyophilized, so it must be reconstituted before any laboratory workflow.

This article is a reference overview, not a protocol. It covers what Cortagen is, where it sits in the research literature and how the compound is categorized, the general reconstitution math and diluent volumes you need, compound-specific handling notes for Cortagen, and the hardware you pair it with — reference pen, 3 ml cartridge, and screw-on pen needle.
Hardware fit (asked often): Our pens take standard 3 ml (300-unit) glass cartridges with the 11 mm long plunger (stopper), the cartridge we sell. 3 ml cartridges are also made with a shorter, about 8 mm plunger, and a pen is built for one height, so check that a cartridge from another source has the 11 mm long plunger before loading it; the glass looks identical from the outside. Pen-needle fit is universal across 28G–33G screw-on tips. We have not tested other manufacturers' cartridges, pens, or needles, so we cannot confirm cross-brand fit — questions about pen model differences and third-party compatibility are answered in the FAQ section.
What it is
Cortagen is a synthetic short-chain peptide supplied for laboratory study. A peptide is a short chain of amino acids — the same building blocks proteins are made from — linked in a defined sequence. Each peptide is named by listing its amino acids in order, so the same four amino acids written in a different order would describe a different molecule.
Compare
| Class | Tetrapeptide — exactly four amino acids |
|---|---|
| Sequence (AEDP) | Alanine – Glutamic acid – Aspartic acid – Proline, read first amino acid to last |
| Family | Khavinson peptide bioregulators — short peptides studied for tissue-function questions |
| Source tissue | Cortexin, a brain-cortex peptide preparation |
| Form supplied | Research vial, intended for laboratory study only |
Where the "bioregulator" label comes from
Members of the Khavinson family were developed by studying peptide extracts prepared from specific body tissues, with each family member corresponding to one source tissue. Cortagen is the synthetic fragment researchers associate with the cortexin extract from the brain cortex, and that link to a named tissue extract is what places it in the bioregulator family. It is supplied as a research-only material — not for administration.
Key point: Cortagen is an unapproved, research-only synthetic tetrapeptide (AEDP) in the Khavinson bioregulator family.
All of our reusable peptide pens (V1, V2, V3 and Gansulin) are compared on one page.
Research context and categorization
Cortagen is a short synthetic peptide developed by Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It is generally categorized as a neural or cortex-related bioregulator and sits within the tissue-specific peptide literature, separate from the metabolic and incretin-mimetic classes that include compounds like tirzepatide and semaglutide.
Where it sits in peptide research
- Class: Short synthetic peptide studied as a tissue-specific bioregulator — a peptide believed to interact with a narrow tissue type.
- Origin: Developed by the Khavinson group at the St. Petersburg Institute of Bioregulation and Gerontology.
- Framing: Often discussed under the "bioregulator hypothesis" — the idea that very short peptides may influence gene expression (the process by which genes in a cell are switched on or off) in specific tissue types, like small keys fitting particular cellular locks.
Investigational areas
Published laboratory and animal-model work has explored topics such as:

- Peripheral nerve regeneration (regrowth of nerves outside the brain and spinal cord) after injury.
- Responses to reduced blood flow in neural tissue.
- Gene-activity patterns in cortical tissue and aging models, including a published microarray study (a lab test that checks many genes' activity at once).
Regulatory status
Cortagen is a research compound. PreppinPeppers sells research hardware (pens, cartridges and bacteriostatic water) and does not sell Cortagen. It has not been reviewed or authorized by the U.S. FDA, and the effects described above are research observations, not confirmed or approved outcomes in humans. They represent ongoing areas of study and should be read as research findings only.
Status
Cortagen is supplied strictly for in-vitro research. It is not approved, and is not sold, for human or animal use.
- Regulatory: Not approved by the U.S. Food and Drug Administration for any indication. Sold as a research compound only - not a drug, dietary supplement, or cosmetic.
- Sport (WADA): Cortagen is not specifically named on the WADA Prohibited List. WADA includes a catch-all category called S0 covering any substance not currently approved by a government health authority for human therapeutic use. Because Cortagen is an unapproved experimental peptide, that provision may apply. Anyone subject to anti-doping rules should confirm current status directly with WADA or their governing body.
- Scope of supply: For laboratory and in-vitro research by qualified research personnel. Not intended, labelled, or supplied for administration to humans or animals.
Reconstitution notes (general)
Reconstitution dissolves a lyophilized powder into a diluent to form a liquid. The resulting concentration equals milligrams of peptide divided by millilitres of diluent; a 20 mg vial brought up in 3 mL yields roughly 6.67 mg/mL. For other vial sizes, use the peptide calculator.
Hardware fit. Our pens take standard 3 ml (300-unit) glass cartridges with the 11 mm long plunger (stopper), the cartridge we sell. 3 ml cartridges are also made with a shorter, about 8 mm plunger, and a pen is built for one height, so check that a cartridge from another source has the 11 mm long plunger before loading it; the glass looks identical from the outside. Cartridge and pen fit have only been verified on our own hardware, so compatibility with third-party cartridge or pen designs has not been tested.
Diluent and stability. Bacteriostatic water contains benzyl alcohol, and peptide stability in solution varies with the specific peptide, concentration, and storage temperature. Colour shifts after reconstitution — for example, GHK-Cu fading from blue toward a paler tone — reflect normal reduction chemistry and are typically expected.
Dilution and handling notes (compound-specific)
Solubility and Appearance
Cortagen is supplied as a lyophilized powder in research vials such as 10 mg, 20 mg, or 50 mg, intended for reconstitution with bacteriostatic water for laboratory workflows. Because Cortagen is a small tetrapeptide with no cysteine residues or disulfide bonds, it dissolves readily into a clear, colorless liquid; cloudiness or particulates are not expected at typical working concentrations.

Researchers sometimes ask why reconstituted peptides change color. A GHK-Cu vial shifting from blue toward clear usually reflects a pH-driven chromophore shift rather than immediate degradation. Cortagen itself is colorless, so any persistent tint or haze is worth checking against the certificate of analysis.
Typical reconstitution volumes fall in the low single-digit millilitre range (for example, 2–3 mL per 20 mg vial, yielding roughly 6.67–10 mg/mL). Diluent volume sets concentration.
Vendor numbers for Cortagen do not always agree, partly because a peptide can be listed as a free acid, a salt, or with different counter-ion assumptions.
Handling Workflow
- Add diluent slowly down the inner glass wall, not directly onto the powder bed.
- Let the vial stand briefly, then swirl gently.
- Swirl gently until clear; avoid vigorous shaking, which introduces foam.
- If particulates persist after gentle swirling, set the vial aside rather than continuing agitation.
- Avoid repeated freeze-thaw cycles; aliquot before storage.
Bacteriostatic Water and Stability
Bacteriostatic water (0.9% benzyl alcohol) is a standard diluent for multi-use research vials. A common question is whether benzyl alcohol degrades peptides in solution; at typical use concentrations it does not meaningfully degrade small tetrapeptides such as Cortagen over short-term storage. Sterile water for injection is a preservative-free option.
Hardware Compatibility
Our pens take standard 3 ml (300-unit) glass cartridges with the 11 mm long plunger (stopper), the cartridge we sell. 3 ml cartridges are also made with a shorter, about 8 mm plunger, and a pen is built for one height, so check that a cartridge from another source has the 11 mm long plunger before loading it; the glass looks identical from the outside. The matching needle format is 28G-33G screw-on pen needles.
Two recurring hardware questions — which cartridges fit, and whether the same cartridges work with other manufacturers' pens — both reduce to the fit spec above. We have not tested third-party hardware, so cross-brand cartridge fit is not something we can verify. Verify cartridge dimensions before loading.
Handling and storage
After reconstitution, store the vial upright in a refrigerator at 2 to 8 °C, shielded from direct light. Discard any remaining solution after roughly four weeks under refrigeration, regardless of volume left in the vial.
Cartridge fit
Our pens take standard 3 ml (300-unit) glass cartridges with the 11 mm long plunger (stopper), the cartridge we sell. 3 ml cartridges are also made with a shorter, about 8 mm plunger, and a pen is built for one height, so check that a cartridge from another source has the 11 mm long plunger before loading it; the glass looks identical from the outside. We have not tested third-party cartridges or third-party pens, so those pairings cannot be confirmed.
Needle fit
Our pens accept any universal 28G–33G screw-on pen needle; attach a fresh needle before each session.
Handling workflow
- Wipe the rubber stopper with an isopropyl alcohol swab before every puncture.
- Mark the reconstitution date on the vial at the time of mixing.
- Return the vial to refrigeration promptly after each withdrawal; avoid freezing the reconstituted solution.
- Discard any vial that becomes cloudy, discolored, or develops visible particles.
Frequently asked questions
What is Cortagen and what is its amino acid sequence?
Cortagen is a synthetic tetrapeptide with the sequence Ala-Glu-Asp-Pro (AEDP), derived from cortexin-based research. It belongs to the Khavinson bioregulator family and is investigated as a neural/brain-cortex research compound.
Is Cortagen prohibited under WADA anti-doping rules?
Cortagen is a research compound. PreppinPeppers sells research hardware (pens, cartridges and bacteriostatic water) and does not sell Cortagen. It is not specifically named on the WADA Prohibited List, but the catch-all S0 category may apply to experimental peptides. Confirm status with WADA directly.
How do you calculate peptide concentration when reconstituting a lyophilized vial?
Divide the milligrams of peptide in the vial by the volume of bacteriostatic water added in milliliters. The result is the concentration in mg/mL. This arithmetic applies to any lyophilized research peptide reconstituted in aqueous solvent.
What the research community gets wrong about Cortagen
Five recurring errors our team sees when researchers handle Cortagen at the bench.
- Conflating Cortagen with Cortexin. Cortexin is a brain-cortex tissue extract containing many components. Cortagen is a single, defined synthetic tetrapeptide (Ala-Glu-Asp-Pro). Handling notes written for one vial do not automatically transfer to the other.
- Reading AEDP as AEDG. Cortagen is Ala-Glu-Asp-Pro. Epitalon is Ala-Glu-Asp-Gly. The abbreviations look nearly identical and some labels swap them. Confirm the three-letter sequence on the COA before trusting any four-letter code.
- Reaching for heavy solvent tricks on a small, soluble peptide. Cortagen has no cysteine residues and no disulfide bonds, so it typically goes into a clear, colorless solution with plain gentle swirling. Warming, sonication, or acidic solvents are not the expected first step. Inbox questions about whether benzyl alcohol affects peptide stability are common; for a sequence like Cortagen the answer sits in how the material behaves in plain bacteriostatic water, not in chasing additive-specific effects.
- Treating the published results as more than an early signal. The peer-reviewed record is a small set of studies, largely from the developing group, in rodent tissue. These describe measurements, not confirmed outcomes, and have not been widely reproduced. Keep any summary framed as what was measured in a study, not as an established effect.
- Quoting a molecular weight or purity figure without checking the COA. Vendor numbers for Cortagen do not always agree, partly because a peptide can be listed as a free acid, a salt, or with different counter-ion assumptions. When a calculation depends on it, verify the molecular weight and purity against the stated formula, sequence, and analytical method on the certificate of analysis rather than copying a number from a product page. Frequent inbox questions — how to read a peptide COA, why certificates are not handed over on demand, whether listings are third-party tested, what a purity guarantee covers — all resolve once the COA is read against the formula on the label.
From our bench: If you have reconstituted a Cortagen vial, we would like your firsthand handling notes. Tell us the vial size (mg), the exact volume of bacteriostatic water you added (mL), and how long the powder took to go fully clear with gentle swirling.
Note whether the finished liquid stayed clear and colorless or showed any haze or floating bits, and at what point you observed it. A color shift away from clear, as some researchers report for other peptides, is worth recording as data, not as a label problem to chase. Please share only your own measured, observed numbers, not figures copied from a label.
Sources
- NCBI PubChem CID 18439621: Cortagen (C17H26N4O9)
- Turchaninova et al., Bull Exp Biol Med 2000: Effect of tetrapeptide cortagen on regeneration of sciatic nerve
- Anisimov et al., Neuro Endocrinol Lett 2004: Elucidation of the effect of brain cortex tetrapeptide Cortagen on gene expression in mouse heart by microarray
- Kolosova et al., Dokl Biol Sci 2002: The delayed effect of cortagen on the restoration of injured nerve function
- Tutel'yan et al., Bull Exp Biol Med 2003: Physiological role of short peptides in nutrition
✔ Reviewed by Bryan Le, PharmD, RPh
Bryan is a licensed pharmacist (Doctor of Pharmacy, Registered Pharmacist). Reconstituting lyophilized preparations is core pharmacy practice, so he reviews The Lab’s content for technical accuracy and to keep it within a research-and-education scope, with no medical or dosing advice. View profile on LinkedIn.
Related entries in the index
For research and educational reference only. Not for human or veterinary use.